Status:
COMPLETED
Prognosis Value of Bioimpedance Analysis (BIA) Phase Angle at Admission in Intensive Care Unit (ICU) Patients
Lead Sponsor:
University Hospital, Geneva
Collaborating Sponsors:
University Hospital, Clermont-Ferrand
Erasme University Hospital
Conditions:
Intensive Care Unit Patients
Eligibility:
All Genders
18+ years
Brief Summary
Critically ill patients feature a loss of fat-free mass (FFM) up to 440 g/day, which is associated with increased morbidity and prolonged recovery. In several clinical conditions, FFM or phase angle (...
Eligibility Criteria
Inclusion
- equal or more than 18 years
- expected ICU length of stay of more than 48 hours
- no readmission within the 48 hours following ICU discharge
- no Implanted Cardiac Devices
- no pregnancy or lactation
- affiliated to health insurance regimen
- informed consent by patient or next of kin.
Exclusion
- age below 18 years
- expected ICU length of stay \<48 hours
- readmission within the 48 hours following ICU discharge
- Implanted Cardiac Devices
- pregnancy or lactation
- non affiliated to health insurance regimen
- no informed consent by patient or next of kin.
Key Trial Info
Start Date :
March 1 2013
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 31 2014
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT01907347
Start Date
March 1 2013
End Date
August 31 2014
Last Update
October 26 2017
Active Locations (10)
Enter a location and click search to find clinical trials sorted by distance.
1
Erasme University Hospital
Brussels, Belgium, 1070
2
Universidade Federal de Pelotas
Pelotas, Brazil
3
Univ. Hospital Center Zagreb
Zagreb, Croatia, Zagreb
4
Clermont-Ferrand University Hospital
Clermont-Ferrand, France, 63009